This preprint is under consideration at Scientific Reports. A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research Article
Guillermo Tellez-Isaias
Department of Poultry Science, University of Arkansas
Corresponding Author
License:
This work is licensed under a CC BY 4.0 License. Read Full License
The purpose of this study was to evaluate and determine the concentration of isoprostane 8‐iso‐PGF2α and prostaglandin GF2α (PGF2α) from plasma and intestine in specific pathogen-free (SPF) chickens challenged with Eimeria maxima (EM) using solid‐phase microextraction and ultra‐performance liquid chromatography/tandem mass spectrometry. Forty one-day-old male SPF chickens were randomly allocated to one of two groups with four replicates (n=5 chickens/replicate). Groups consisted of Control (no challenge) or the Challenge group EM (40,000 sporulated oocysts/bird). At day 7 and 9 post-challenge, half of the chickens were euthanized in both groups to determine plasmatic and enteric concentrations of isoprostane 8‐iso‐PGF2α and PGF2α. Enteric levels of both 8‐iso‐PGF2α and PGF2α were significantly increased at 7 (8‐iso‐PGF2α P=0.0000252; PGF2α P=0.00000268) and 9 days (8‐iso‐PGF2α P=0.000000717; PGF2α P=0.00000222) post-challenge compared to non-challenge control chickens. However, plasma levels of isoprostane 8‐iso‐PGF2α and PGF2α were similar in both groups. A significant reduction (P=0.0000095) in oocyst excretion was observed in chickens at 9 days post-challenge compared to 7 days. Chickens challenged with EM showed an inflammatory response associated with significant increases in enteric PGF2α and 8-Iso-PGF2α, suggesting that the active disease phase was accompanied by inflammation and oxidative stress within the intestinal layer.
Keywords
chickens, Eimeria maxima, isoprostane 8‐iso‐PGF2α, PGF2α, intestine, prostaglandin
Figure 1
Figure 2
Figure 3
No competing interests reported.
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Under Revision
Version 1
Posted 15 Mar, 2021
No community comments so far
Editorial decision: Major revision
On 08 Apr, 2021
Review #4 received
Received 29 Mar, 2021
Review #3 received
Received 29 Mar, 2021
Review #1 received
Received 29 Mar, 2021
Review #2 received
Received 29 Mar, 2021
Reviewer #7 agreed
On 21 Mar, 2021
Reviewer #2 agreed
On 21 Mar, 2021
Reviewer #4 agreed
On 21 Mar, 2021
Reviewer #3 agreed
On 21 Mar, 2021
Reviewer #1 agreed
On 16 Mar, 2021
Reviewer #10 agreed
On 16 Mar, 2021
Reviewer #5 agreed
On 16 Mar, 2021
Reviewer #17 agreed
On 16 Mar, 2021
Reviewer #12 agreed
On 16 Mar, 2021
Reviewer #6 agreed
On 16 Mar, 2021
Reviewer #11 agreed
On 16 Mar, 2021
Reviewer #16 agreed
On 16 Mar, 2021
Reviewer #14 agreed
On 16 Mar, 2021
Reviewer #13 agreed
On 16 Mar, 2021
Reviewer #15 agreed
On 16 Mar, 2021
Reviewers invited
Invitations sent on 16 Mar, 2021
Editor assigned
On 16 Mar, 2021
Editor invited
On 10 Mar, 2021
Submission checks complete
On 10 Mar, 2021
First submitted
On 01 Mar, 2021
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Learn more about our company.
This preprint is under consideration at Scientific Reports. A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research Article
Guillermo Tellez-Isaias
Department of Poultry Science, University of Arkansas
Corresponding Author
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Under Revision
Version 1
Posted 15 Mar, 2021
No community comments so far
Editorial decision: Major revision
On 08 Apr, 2021
Review #4 received
Received 29 Mar, 2021
Review #3 received
Received 29 Mar, 2021
Review #1 received
Received 29 Mar, 2021
Review #2 received
Received 29 Mar, 2021
Reviewer #7 agreed
On 21 Mar, 2021
Reviewer #2 agreed
On 21 Mar, 2021
Reviewer #4 agreed
On 21 Mar, 2021
Reviewer #3 agreed
On 21 Mar, 2021
Reviewer #1 agreed
On 16 Mar, 2021
Reviewer #10 agreed
On 16 Mar, 2021
Reviewer #5 agreed
On 16 Mar, 2021
Reviewer #17 agreed
On 16 Mar, 2021
Reviewer #12 agreed
On 16 Mar, 2021
Reviewer #6 agreed
On 16 Mar, 2021
Reviewer #11 agreed
On 16 Mar, 2021
Reviewer #16 agreed
On 16 Mar, 2021
Reviewer #14 agreed
On 16 Mar, 2021
Reviewer #13 agreed
On 16 Mar, 2021
Reviewer #15 agreed
On 16 Mar, 2021
Reviewers invited
Invitations sent on 16 Mar, 2021
Editor assigned
On 16 Mar, 2021
Editor invited
On 10 Mar, 2021
Submission checks complete
On 10 Mar, 2021
First submitted
On 01 Mar, 2021
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
License:
This work is licensed under a CC BY 4.0 License. Read Full License
The purpose of this study was to evaluate and determine the concentration of isoprostane 8‐iso‐PGF2α and prostaglandin GF2α (PGF2α) from plasma and intestine in specific pathogen-free (SPF) chickens challenged with Eimeria maxima (EM) using solid‐phase microextraction and ultra‐performance liquid chromatography/tandem mass spectrometry. Forty one-day-old male SPF chickens were randomly allocated to one of two groups with four replicates (n=5 chickens/replicate). Groups consisted of Control (no challenge) or the Challenge group EM (40,000 sporulated oocysts/bird). At day 7 and 9 post-challenge, half of the chickens were euthanized in both groups to determine plasmatic and enteric concentrations of isoprostane 8‐iso‐PGF2α and PGF2α. Enteric levels of both 8‐iso‐PGF2α and PGF2α were significantly increased at 7 (8‐iso‐PGF2α P=0.0000252; PGF2α P=0.00000268) and 9 days (8‐iso‐PGF2α P=0.000000717; PGF2α P=0.00000222) post-challenge compared to non-challenge control chickens. However, plasma levels of isoprostane 8‐iso‐PGF2α and PGF2α were similar in both groups. A significant reduction (P=0.0000095) in oocyst excretion was observed in chickens at 9 days post-challenge compared to 7 days. Chickens challenged with EM showed an inflammatory response associated with significant increases in enteric PGF2α and 8-Iso-PGF2α, suggesting that the active disease phase was accompanied by inflammation and oxidative stress within the intestinal layer.
Figure 1
Figure 2
Figure 3
Loading...